News for 'Consumer Healthcare'

Jharkhand air ambulance crash: DGCA begins probe

Jharkhand air ambulance crash: DGCA begins probe

Rediff.com25 Feb 2026

The Directorate General of Civil Aviation (DGCA) has launched an investigation into the air ambulance crash in Jharkhand's Chatra district that killed all seven people on board. Two teams from the DGCA are probing the accident, while families mourn the loss of their loved ones.

Open offers highest since 2008 as acquisition, takeover attempts surge

Open offers highest since 2008 as acquisition, takeover attempts surge

Rediff.com29 Dec 2025

Open offers this calendar year, following attempts at acquisition and takeover, came in at more than two a week. There were 121 such open offers to acquire additional shares following a substantial acquisition or change of control, shows the data compiled by primedatabase.com.

Ahead of IPO, Practo eyes $1 bn GMV

Ahead of IPO, Practo eyes $1 bn GMV

Rediff.com30 Dec 2025

Digital healthcare platform Practo is targeting annualised gross merchandise value (GMV) of $1 billion by June 2026, with its expanding US operations expected to contribute between $250 million and $300 million, according to people familiar with the company's plans.

Seniors to Drive 25% of India's Pharma

Seniors to Drive 25% of India's Pharma

Rediff.com21 Nov 2025

'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to dominate the market for the next several decades.'

Women Power India's Retail Push

Women Power India's Retail Push

Rediff.com5 Jan 2026

'It's harder to attract women initially, but once they come in, retention is significantly higher.'

Tamil Nadu bets big on India's first full-stack sovereign AI park

Tamil Nadu bets big on India's first full-stack sovereign AI park

Rediff.com14 Jan 2026

The sovereign AI park will be a first-of-its-kind, purpose-built district in India, integrating AI compute infrastructure, secure data frameworks, model research labs, and AI innovation clusters, along with a dedicated institute for AI in governance.

India terms EU envoys' article unusual before key Putin visit

India terms EU envoys' article unusual before key Putin visit

Rediff.com3 Dec 2025

India and Russia are poised to sign multiple agreements to bolster cooperation in various sectors, including trade and healthcare, during Russian President Vladimir Putin's visit to New Delhi. Discussions will also address the Ukraine conflict and efforts to increase Indian exports to Russia.

Global Investing: What YOU Must Know

Global Investing: What YOU Must Know

Rediff.com16 Oct 2025

Here's what Indian investors diversifying into equities, ETFs, and real estate abroad to manage risk, returns, and currency exposure must watch out for.

How To Deal with Medical Negligence

How To Deal with Medical Negligence

Rediff.com10 Oct 2025

Medical negligence arises when a medical professional deviates from reasonable standards of care, causing injury to the patient.

WHO issues alert against Indian cough syrups. They are...

WHO issues alert against Indian cough syrups. They are...

Rediff.com14 Oct 2025

The World Health Organisation (WHO) has issued an alert against three "substandard" oral cough syrups identified in India and urged national regulatory authorities worldwide to immediately notify it if these are detected in their country.

Pan masala cess to boost public health, security

Pan masala cess to boost public health, security

Rediff.com8 Dec 2025

Experts said that earmarking of funds for public health at par with national security indicates a key policy shift.

Tier-II, -III mkts make 62% of new health insurance policies

Tier-II, -III mkts make 62% of new health insurance policies

Rediff.com12 Dec 2025

Tier-II, Tier-III, and rural regions accounted for 62 per cent of all new health insurance policies sold by insurers so far in 2025-26 (FY26), according to a Policybazaar report. These regions are also witnessing a rise in the sum assured opted by customers.

Don't Let Your Health Cover Fall Short

Don't Let Your Health Cover Fall Short

Rediff.com6 Jan 2026

With medical inflation hovering at around 13-14 per cent annually, policyholders must reassess their sum insured once every two years.

FPIs resume selling in Nov; withdraw Rs 3,765 cr from equities

FPIs resume selling in Nov; withdraw Rs 3,765 cr from equities

Rediff.com30 Nov 2025

After a brief pause in October, foreign investors resumed selling, pulling out a net Rs 3,765 crore from Indian equities in November, driven by global risk-off sentiment, volatility in global tech stocks and selective preference for primary markets over secondary markets.

AHPI, Star Health in spat over cashless service

AHPI, Star Health in spat over cashless service

Rediff.com15 Sep 2025

If cashless services are suspended, AHPI said, its member hospitals will continue to treat Star Health policyholders, but patients will have to pay upfront and later seek reimbursements directly from the insurer.

Reliance investments in AI infra may top $12-15 bn

Reliance investments in AI infra may top $12-15 bn

Rediff.com26 Oct 2025

Billionaire Mukesh Ambani's Reliance Industries Ltd may spend about $12-15 billion over the next few years on AI infrastructure that could include a giant 1GW data centre, Morgan Stanley said in a report. Ambani had at the company's annual shareholder meeting in August announced a major push into AI through a new subsidiary and strategic partnerships.

When Do You Introduce Spice To A Baby?

When Do You Introduce Spice To A Baby?

Rediff.com18 Nov 2025

You can slowly build up spices over six to nine months by adding ajwain, jeera, coriander, cardamom and cinnamon powders for flavouring different recipes, says Madhavi Bhardwaj.

India, New Zealand conclude FTA negotiations

India, New Zealand conclude FTA negotiations

Rediff.com22 Dec 2025

New Zealand Prime Minister Christopher Luxon on Monday said the negotiations for a free trade agreement with India have been concluded.

Core acquisition adds to Metropolis Healthcare's long-term growth plans

Core acquisition adds to Metropolis Healthcare's long-term growth plans

Rediff.com27 Dec 2024

Metropolis Healthcare (MHL) has decided to acquire a 100 per cent stake in Gurgaon-based Core Diagnostics for Rs 247 crore. This is about 2.2x FY24 (financial year 2023-24) enterprise value (EV)/sales and estimated 14x FY26 EV/Ebitda for the deal.

Bajaj Finserv targets a 22% profit CAGR, double customers in 5 years

Bajaj Finserv targets a 22% profit CAGR, double customers in 5 years

Rediff.com8 Dec 2025

Bajaj Finserv - the holding company of Bajaj group's financial services business - has laid out plans for the next five years. During this period, it is eyeing 18-22 per cent compound annual growth rate (CAGR) in net profit at Rs 21,000-24,000 crore on a consolidated basis.

Sarvam AI To Launch India's First LLM In Feb

Sarvam AI To Launch India's First LLM In Feb

Rediff.com20 Nov 2025

Sarvam's LLM will have more than 17 trillion tokens with 17 to 20 per cent coming from Indian data

'Govt Has Executed A Commendable Task'

'Govt Has Executed A Commendable Task'

Rediff.com5 Dec 2025

'...not merely in managing fiscal mathematics, but in demonstrating conservatism and prudence within that framework.' 'Looking forward, we believe sufficient growth drivers exist -- ranging from government reforms to revival in consumption to favourable monsoons. Numerous factors support the Indian economy.'

No deaths due to codeine syrup, accused linked to SP: Yogi

No deaths due to codeine syrup, accused linked to SP: Yogi

Rediff.com22 Dec 2025

Uttar Pradesh Chief Minister Yogi Adityanath on Monday strongly rebutted allegations by Leader of Opposition Mata Prasad Pandey over 'deaths' allegedly due to the consumption of fake medicines and codeine syrup, asserting in the Assembly that no such case has come to the notice of the state government so far.

No cashless treatment for Bajaj Allianz customers of north India

No cashless treatment for Bajaj Allianz customers of north India

Rediff.com22 Aug 2025

The Association of Healthcare Providers - India (AHPI), representing hospitals and healthcare institutions across the country, has advised its members in north India to stop providing cashless treatment facilities for policyholders of Bajaj Allianz General Insurance Company, with effect from September 1.

Want To Invest In US Markets? Read This

Want To Invest In US Markets? Read This

Rediff.com24 Nov 2025

New investors or those with lower-than-planned exposure should add US-oriented funds through SIPs.

Wipro Q2 profit inches up; launches 'Wipro Intelligence' to boost AI push

Wipro Q2 profit inches up; launches 'Wipro Intelligence' to boost AI push

Rediff.com16 Oct 2025

IT services firm Wipro on Thursday reported a marginal increase in consolidated net profit to Rs 3,246.2 crore in the July-September quarter, even as company CEO and MD Srini Pallia asserted that the demand environment remains robust with discretionary spends shifting towards AI-related projects.

iPhone Affordability Index Reveals: Most Indians Can't...

iPhone Affordability Index Reveals: Most Indians Can't...

Rediff.com16 Sep 2025

The average Indian worker must labour for an extraordinary 160 full working days to afford Apple's latest iPhone 17 Pro.

How GST Rate Cut Will Impact Sectors

How GST Rate Cut Will Impact Sectors

Rediff.com8 Sep 2025

Lower rates effectively increase disposable income, strengthen purchasing capacity, and support broader consumption growth.

Amazon enters India's $15 bn diagnostics market with At-Home testing

Amazon enters India's $15 bn diagnostics market with At-Home testing

Rediff.com23 Jun 2025

Amazon India has launched Amazon Diagnostics, an at-home healthcare service that allows customers to book lab tests, schedule appointments and receive digital reports directly via the Amazon app. Initially available in six cities-Bengaluru, Delhi, Gurgaon, Noida, Mumbai and Hyderabad-the service covers more than 450 PIN codes and offers access to over 800 diagnostic tests.

'No Such Thing As Diabetes Reversal'

'No Such Thing As Diabetes Reversal'

Rediff.com14 Nov 2025

'In diabetes remission, you go below a 6.5 HbA1c without medication.' 'And this happens only when you lose 10 to 15 per cent of your body weight with a good amount of lifestyle and dietary changes, exercise and sometimes medication.' 'You have to be able to sustain your HBA1C below 6.5 for at least a year without medication to say that the patient is in remission.'

Cashless Facility On Hold? How To Manage

Cashless Facility On Hold? How To Manage

Rediff.com15 Oct 2025

To handle the sudden loss of cashless facility, patients should maintain an emergency fund or a short-term credit line to manage all or part of hospitalisation costs.

GST 2.0: These will get cheaper from September 22

GST 2.0: These will get cheaper from September 22

Rediff.com4 Sep 2025

Some of the key names include: Maruti, M&M, Ashok Leyland, Britannia, Ultratech, JK Cement, Havells, Voltas, Amber, Metro, Trent, LemonTree, Indian Hotels, Niva Bupa, HDFC Life, IGL, Acme Solar, Suzlon, Swiggy, Delhivery, ICICI Bank, HDFC Bank, Bajaj Finance, Shriram Finance," according to a report by Motilal Oswal Financial Services.

Stocks of domestic-facing firms lag despite tariff-related hedge calls

Stocks of domestic-facing firms lag despite tariff-related hedge calls

Rediff.com1 Sep 2025

To shield against US President Donald Trump's tariff shock, analysts have been advising investors to focus on stocks of domestic-oriented companies, rather than export-centric ones, to minimise potential losses.

Ditch Quick-Money Lures This Diwali!

Ditch Quick-Money Lures This Diwali!

Rediff.com20 Oct 2025

: Build lasting wealth via disciplined, long-term mutual fund investing in India's compounding marathon, Shanaihi, Shanaihi, says Ramalingam Kalirajan

Smallcaps Face Their Toughest Samvat Yet

Smallcaps Face Their Toughest Samvat Yet

Rediff.com18 Oct 2025

'Defence, capital goods, engineering, capital market-related stocks, autos, and cement sectors are my bullish bets for Samvat 2082.'

IPL's Valuation Hits Flat Pitch

IPL's Valuation Hits Flat Pitch

Rediff.com16 Oct 2025

The IPL's overall valuation fell by 8 per cent to Rs 76,100 crore in 2025.

Small is big for PEs, companies as M&As rise to $45.4 billion in H1

Small is big for PEs, companies as M&As rise to $45.4 billion in H1

Rediff.com11 Jul 2025

India's mergers & acquisitions (M&As) market recorded deals worth $45.44 billion in the first half of 2025, up nearly 3.3 per cent from a year ago, even as ultra large-ticket transactions remained subdued. During the first half, the 7.1 per cent rise in deal count to 1,614 signals continuing appetite among domestic conglomerates and private equity (PE) funds for mid-sized and smaller assets.

CBSE's 'sugar boards' in schools aim to curb childhood obesity

CBSE's 'sugar boards' in schools aim to curb childhood obesity

Rediff.com25 May 2025

The Central Board of Secondary Education (CBSE) has directed schools to set up dedicated 'Sugar Boards' to raise awareness about sugar consumption and combat childhood obesity. Experts hail the initiative as a significant step towards promoting healthier dietary habits among students and families. The boards will display information on the sugar content in common snacks, drinks, and meals, helping children make informed choices. This move comes as data reveals alarmingly high sugar intake among Indian children, exceeding the World Health Organization's recommended limits.

'Next Samvat Could See Equities Align With Economic Growth'

'Next Samvat Could See Equities Align With Economic Growth'

Rediff.com16 Oct 2025

'The outlook for the next Samvat is more constructive, as many of the earlier drags are gradually becoming supports.'

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.